电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

HLA-A*11:01 (AA 25-305), (Monomer) protein (His-Avi Tag,KRAS G12S)

This Recombinant protein is expressed in HEK-293 Cells.
产品编号 ABIN7454291
发货至: 中国

Quick Overview for HLA-A*11:01 (AA 25-305), (Monomer) protein (His-Avi Tag,KRAS G12S) (ABIN7454291)

抗原

HLA-A*11:01

蛋白类型

Recombinant

宿主

资源

  • 31
  • 7
  • 1
HEK-293 Cells

纯度

> 95 % as determined by Tris-Bis PAGE,> 95 % as determined by HPLC
  • 产品特性

    AA 25-305, Monomer

    标记

    His-Avi Tag,KRAS G12S

    原理

    Human HLA-A*11:01&B2M&KRAS G12S (VVVGASGVGK) Monomer Protein

    序列

    Gly25-Thr305(HLA-A*11:01), Ile21-Met119(B2M)and VVVGASGVGK peptide

    特异性

    Uni-Prot: AAV53343.1 (HLA-A*11:01), P61769 (B2M), VVVGASGVGK

    产品特性

    Recombinant Human HLA-A*11:01&B2M&KRAS G12S (VVVGASGVGK) Monomer Protein is expressed from HEK293 with His tag and Avi tag at the C-Terminus.It contains Gly25-Thr305(HLA-A*11:01), Ile21-Met119(B2M) and VVVGASGVGK peptide.

    过滤

    0.22 μm filtered

    内毒素水平

    Less than 1EU per μg by the LAL method.
  • 想要此Protein的其他选项吗?

    !
    探索我们的预定义定制蛋白和定制蛋白服务!

    您的项目需要进一步定制吗?联系我们,了解我们的定制蛋白解决方案

  • 限制

    仅限研究用
  • 状态

    Lyophilized

    溶解方式

    Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/mL is recommended. Dissolve the lyophilized protein in distilled water.

    缓冲液

    Lyophilized from 0.22μm filtered solution in PBS ( pH 7.4). Normally 8 % trehalose is added as protectant before lyophilization.

    储存条件

    -20 °C,-80 °C

    储存方法

    -20 to -80°C for 12 months as supplied from date of receipt.,-80°C for 3-6 months after reconstitution.,2-8°C for 2-7 days after reconstitution.,Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.

    有效期

    12 months
  • 抗原

    HLA-A*11:01

    背景

    Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail.

    分子量

    50.30 kDa. Due to glycosylation, the protein migrates to 53-63 kDa based on Tris-Bis PAGE result.
You are here:
Chat with us!